Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

NCT00331409 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

DRUG: Everolimus
DRUG: imatinib mesylate

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]